Laboratory Of Stock Analysis
| LH Stock | USD 289.89 5.39 1.89% |
IPO Date 29th of March 1990 | 200 Day MA 262.5453 | 50 Day MA 262.4094 | Beta 0.996 |
Laboratory holds a debt-to-equity ratio of 0.628. As of now, Laboratory's Short and Long Term Debt is increasing as compared to previous years. The Laboratory's current Debt To Equity is estimated to increase to 1.19, while Long Term Debt is projected to decrease to under 3.3 B. With a high degree of financial leverage come high-interest payments, which usually reduce Laboratory's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Laboratory's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Laboratory's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Laboratory Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Laboratory's stakeholders.
For many companies, including Laboratory, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Laboratory of, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Laboratory's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 2.6119 | Enterprise Value Ebitda 14.2389 | Price Sales 1.6542 | Shares Float 82.5 M | Dividend Share 2.88 |
Laboratory of is undervalued with Real Value of 314.52 and Target Price of 300.18. The main objective of Laboratory stock analysis is to determine its intrinsic value, which is an estimate of what Laboratory of is worth, separate from its market price. There are two main types of Laboratory's stock analysis: fundamental analysis and technical analysis.
The Laboratory stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Laboratory's ongoing operational relationships across important fundamental and technical indicators.
Laboratory | Build AI portfolio with Laboratory Stock |
Laboratory Stock Analysis Notes
About 98.0% of the company shares are owned by institutional investors. The book value of Laboratory was now reported as 104.78. The company has Price/Earnings To Growth (PEG) ratio of 2.01. Laboratory recorded earning per share (EPS) of 10.19. The entity last dividend was issued on the 27th of February 2026. The firm had 1164:1000 split on the 3rd of July 2023. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina. Laboratory Corp operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 75000 people. To find out more about Laboratory of contact Paul Kirchgraber at 336-584-5171 or learn more at https://www.labcorp.com.Laboratory Quarterly Total Revenue |
|
Laboratory Investment Alerts
| Laboratory has a very strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of tradable shares by Bailey Megan D. of Laboratory at 274.01 subject to Rule 16b-3 |
Laboratory Largest EPS Surprises
Earnings surprises can significantly impact Laboratory's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
1997-07-29 | 1997-06-30 | 0.06 | 0.05 | -0.01 | 16 | ||
1999-07-22 | 1999-06-30 | 0.13 | 0.15 | 0.02 | 15 | ||
1998-03-17 | 1997-12-31 | -0.12 | -0.1 | 0.02 | 16 |
Laboratory Environmental, Social, and Governance (ESG) Scores
Laboratory's ESG score is a quantitative measure that evaluates Laboratory's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Laboratory's operations that may have significant financial implications and affect Laboratory's stock price as well as guide investors towards more socially responsible investments.
Laboratory Stock Institutional Investors
| Shares | Fmr Inc | 2025-06-30 | 1.7 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.5 M | Amvescap Plc. | 2025-06-30 | 1.3 M | Jpmorgan Chase & Co | 2025-06-30 | 1.3 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.3 M | Alliancebernstein L.p. | 2025-06-30 | 1.1 M | Veritas Investment Partners (uk) Ltd. | 2025-06-30 | 1.1 M | Northern Trust Corp | 2025-06-30 | 1.1 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1 M | Vanguard Group Inc | 2025-06-30 | 9.9 M | Blackrock Inc | 2025-06-30 | 9.1 M |
Laboratory Market Capitalization
The company currently falls under 'Large-Cap' category with a market capitalization of 22.77 B.Laboratory Profitablity
The company has Net Profit Margin (PM) of 0.06 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.11 %, which signifies that for every $100 of sales, it has a net operating income of $0.11.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.14 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.05 | 0.09 | |
| Return On Equity | 0.11 | 0.18 |
Management Efficiency
Laboratory has Return on Asset (ROA) of 0.0463 % which means that for every $100 of assets, it generated a profit of $0.0463. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1014 %, which means that it produced $0.1014 on every 100 dollars invested by current stockholders. Laboratory's management efficiency ratios could be used to measure how well Laboratory manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Laboratory's Return On Tangible Assets are decreasing as compared to previous years. The Laboratory's current Return On Assets is estimated to increase to 0.09, while Return On Capital Employed is projected to decrease to 0.08. As of now, Laboratory's Total Current Assets are increasing as compared to previous years. The Laboratory's current Other Assets is estimated to increase to about 787.5 M, while Non Currrent Assets Other are projected to decrease to under 399 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 86.53 | 90.86 | |
| Tangible Book Value Per Share | (24.56) | (25.79) | |
| Enterprise Value Over EBITDA | 12.42 | 8.02 | |
| Price Book Value Ratio | 2.75 | 3.26 | |
| Enterprise Value Multiple | 12.42 | 8.02 | |
| Price Fair Value | 2.75 | 3.26 | |
| Enterprise Value | 7.4 B | 7.8 B |
Examining the leadership quality of Laboratory of offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Technical Drivers
As of the 11th of February 2026, Laboratory secures the Mean Deviation of 1.03, risk adjusted performance of 0.126, and Downside Deviation of 1.08. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratory, as well as the relationship between them.Laboratory Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Laboratory price series with the more recent values given greater weights.
Laboratory Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Laboratory insiders, such as employees or executives, is commonly permitted as long as it does not rely on Laboratory's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Laboratory insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Laboratory Outstanding Bonds
Laboratory issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Laboratory uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Laboratory bonds can be classified according to their maturity, which is the date when Laboratory of has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Laboratory Predictive Daily Indicators
Laboratory intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Laboratory stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 22123.14 | |||
| Daily Balance Of Power | 0.6814 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 286.19 | |||
| Day Typical Price | 287.42 | |||
| Price Action Indicator | 6.4 | |||
| Period Momentum Indicator | 5.39 |
Laboratory Corporate Filings
F4 | 10th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 9th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 29th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 15th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 14th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 12th of January 2026 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 30th of December 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 15th of December 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Laboratory Forecast Models
Laboratory's time-series forecasting models are one of many Laboratory's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Laboratory's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Laboratory Bond Ratings
Laboratory of financial ratings play a critical role in determining how much Laboratory have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Laboratory's borrowing costs.| Piotroski F Score | 9 | Very Strong | View |
| Beneish M Score | (2.51) | Unlikely Manipulator | View |
Laboratory Debt to Cash Allocation
As Laboratory of follows its natural business cycle, the capital allocation decisions will not magically go away. Laboratory's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Laboratory of reports 7.27 B of total liabilities with total debt to equity ratio (D/E) of 0.63, which is normal for its line of buisiness. Laboratory has a current ratio of 1.7, which is generally considered normal. Nevertheless, prudent borrowing could serve as an effective mechanism for Laboratory to finance growth opportunities yielding strong returns. Laboratory Common Stock Shares Outstanding Over Time
Laboratory Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Laboratory uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Laboratory Debt Ratio | 41.0 |
Laboratory Corporate Bonds Issued
Most Laboratory bonds can be classified according to their maturity, which is the date when Laboratory of has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Laboratory Net Debt
Net Debt |
|
About Laboratory Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Laboratory prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Laboratory shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Laboratory. By using and applying Laboratory Stock analysis, traders can create a robust methodology for identifying Laboratory entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.08 | 0.14 | |
| Operating Profit Margin | 0.10 | 0.17 | |
| Net Profit Margin | 0.05 | 0.07 | |
| Gross Profit Margin | 0.32 | 0.42 |
Current Laboratory Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Laboratory analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Laboratory analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 300.18 | Strong Buy | 20 | Odds |
Most Laboratory analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Laboratory stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Laboratory, talking to its executives and customers, or listening to Laboratory conference calls.
Laboratory Stock Analysis Indicators
Laboratory of stock analysis indicators help investors evaluate how Laboratory stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Laboratory shares will generate the highest return on investment. By understating and applying Laboratory stock analysis, traders can identify Laboratory position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 536.8 M | |
| Long Term Debt | 5.3 B | |
| Common Stock Shares Outstanding | 84.4 M | |
| Total Stockholder Equity | 8.1 B | |
| Total Cashflows From Investing Activities | -1.4 B | |
| Tax Provision | 212.4 M | |
| Quarterly Earnings Growth Y O Y | 0.56 | |
| Property Plant And Equipment Net | 3 B | |
| Cash And Short Term Investments | 1.5 B | |
| Cash | 1.5 B | |
| Accounts Payable | 875.8 M | |
| Net Debt | 5.8 B | |
| 50 Day M A | 262.4094 | |
| Total Current Liabilities | 3.3 B | |
| Other Operating Expenses | 11.9 B | |
| Non Current Assets Total | 13.6 B | |
| Forward Price Earnings | 15.4799 | |
| Non Currrent Assets Other | 652.2 M | |
| Stock Based Compensation | 116.7 M |
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |